Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 366

1.

Renal cell tumors with an entrapped papillary component: a collision with predilection for oncocytic tumors.

Williamson SR, Cheng L, Gadde R, Giannico GA, Wasco MJ, Taylor Smith PJ, Gupta NS, Grignon DJ, Jorda M, Kryvenko ON.

Virchows Arch. 2019 Aug 23. doi: 10.1007/s00428-019-02648-z. [Epub ahead of print]

PMID:
31444626
2.

Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter-Nephroureterectomy and Ureterectomy Specimens: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Samaratunga H, Judge M, Delahunt B, Srigley J, Brimo F, Comperat E, Koch M, Lopez-Beltran A, Reuter V, Shanks J, Tsuzuki T, van der Kwast T, Varma M, Grignon D.

Am J Surg Pathol. 2019 Oct;43(10):e1-e12. doi: 10.1097/PAS.0000000000001305.

PMID:
31192862
3.

MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.

Magers MJ, Iczkowski KA, Montironi R, Grignon DJ, Zhang S, Williamson SR, Yang X, Wang M, Osunkoya AO, Lopez-Beltran A, Hes O, Eble JN, Cheng L.

Mod Pathol. 2019 Jun 12. doi: 10.1038/s41379-019-0297-6. [Epub ahead of print]

PMID:
31189999
4.

Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.

Al-Obaidy KI, Eble JN, Cheng L, Williamson SR, Sakr WA, Gupta N, Idrees MT, Grignon DJ.

Am J Surg Pathol. 2019 Aug;43(8):1099-1111. doi: 10.1097/PAS.0000000000001288.

PMID:
31135486
5.

Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.

Perrino CM, Eble J, Kao CS, Whaley RD, Cheng L, Idrees M, Hashemi-Sadraei N, Monn MF, Kaimakliotis HZ, Bandali E, Grignon D.

Hum Pathol. 2019 Aug;90:27-36. doi: 10.1016/j.humpath.2019.04.012. Epub 2019 May 3.

PMID:
31054897
6.

Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR).

Shanks JH, Srigley JR, Brimo F, Comperat E, Delahunt B, Koch M, Lopez-Beltran A, Reuter VE, Samaratunga H, Tsuzuki T, van der Kwast T, Varma M, Grignon D.

Histopathology. 2019 Apr 22. doi: 10.1111/his.13877. [Epub ahead of print] Review.

PMID:
31009090
7.

DOG1 immunohistochemical staining of testicular biopsies is a reliable tool for objective assessment of infertility.

Salama R, Al-Obaidy KI, Perrino CM, Grignon DJ, Ulbright TM, Idrees MT.

Ann Diagn Pathol. 2019 Jun;40:18-22. doi: 10.1016/j.anndiagpath.2019.02.015. Epub 2019 Feb 20.

PMID:
30849695
8.

Primary Renal Synovial Sarcomas: PAX 8 Immunostaining and Unusual Molecular Findings.

Rose L, Grignon D, Cheng L, Fan R, Zhang S, Alruwaii F, Chen S.

Appl Immunohistochem Mol Morphol. 2019 Feb 15. doi: 10.1097/PAI.0000000000000736. [Epub ahead of print]

PMID:
30789354
9.

Adenocarcinoma of the Rete Testis: Clinicopathologic and Immunohistochemical Characterization of 6 Cases and Review of the Literature.

Al-Obaidy KI, Idrees MT, Grignon DJ, Ulbright TM.

Am J Surg Pathol. 2019 May;43(5):670-681. doi: 10.1097/PAS.0000000000001219.

PMID:
30676333
10.

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.

Dignam JJ, Hamstra DA, Lepor H, Grignon D, Brereton H, Currey A, Rosenthal S, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Sandler HM.

J Clin Oncol. 2019 Jan 20;37(3):213-221. doi: 10.1200/JCO.18.00154. Epub 2018 Dec 7.

PMID:
30526194
11.

SIU-ICUD on bladder cancer: pathology.

Compérat E, Babjuk M, Algaba F, Amin M, Brimo F, Grignon D, Hansel D, Hes O, Malavaud B, Reuter V, van der Kwast T.

World J Urol. 2019 Jan;37(1):41-50. doi: 10.1007/s00345-018-2466-5. Epub 2018 Sep 14.

PMID:
30218308
12.

Immunohistochemical characteristics of renomedullary interstitial cell tumor: a study of 41 tumors with emphasis on differential diagnosis of mesenchymal neoplasms.

Lu Z, Al-Obaidy K, Cheng L, Perry KD, Grignon DJ, Williamson SR.

Hum Pathol. 2018 Dec;82:46-50. doi: 10.1016/j.humpath.2018.07.010. Epub 2018 Jul 18.

PMID:
30031100
13.

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck S, Grignon DJ, Cheng L, Albany C, Hahn NM.

Urol Oncol. 2018 Jul;36(7):345. doi: 10.1016/j.urolonc.2018.05.003. Epub 2018 Jun 5.

PMID:
29880459
14.

Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists.

Williamson SR, Rao P, Hes O, Epstein JI, Smith SC, Picken MM, Zhou M, Tretiakova MS, Tickoo SK, Chen YB, Reuter VE, Fleming S, Maclean FM, Gupta NS, Kuroda N, Delahunt B, Mehra R, Przybycin CG, Cheng L, Eble JN, Grignon DJ, Moch H, Lopez JI, Kunju LP, Tamboli P, Srigley JR, Amin MB, Martignoni G, Hirsch MS, Bonsib SM, Trpkov K.

Am J Surg Pathol. 2018 Sep;42(9):1253-1261. doi: 10.1097/PAS.0000000000001087.

PMID:
29878933
15.

Utility of Pathology Imagebase for standardisation of prostate cancer grading.

Egevad L, Delahunt B, Berney DM, Bostwick DG, Cheville J, Comperat E, Evans AJ, Fine SW, Grignon DJ, Humphrey PA, Hörnblad J, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, Magi-Galluzzi C, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, True LD, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M.

Histopathology. 2018 Jul;73(1):8-18. doi: 10.1111/his.13471. Epub 2018 Mar 5.

PMID:
29359484
16.

Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.

Grignon DJ.

Mod Pathol. 2018 Jan;31(S1):S96-109. doi: 10.1038/modpathol.2017.167. Review.

17.

Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex.

Williamson SR, Hornick JL, Eble JN, Gupta NS, Rogers CG, True L, Grignon DJ, Cheng L.

Hum Pathol. 2018 May;75:10-15. doi: 10.1016/j.humpath.2017.11.013. Epub 2017 Nov 24.

PMID:
29180251
18.

Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press.

Williamson SR, Grignon DJ, Calió A, Stohr BA, Eble JN, Cheng L.

Mod Pathol. 2017 Oct;30(10):1509-1511. doi: 10.1038/modpathol.2017.84. No abstract available.

19.

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.

Caliò A, Eble JN, Hes O, Martignoni G, Harari SE, Williamson SR, Brunelli M, Osunkoya AO, Wang L, Comperat E, Lopez-Beltran A, Wang M, Zhang S, Curless KL, Post KM, Chang HY, Luchini C, Baldrige LA, MacLennan GT, Montironi R, Grignon DJ, Cheng L.

Oncotarget. 2016 Aug 8;8(33):54096-54105. doi: 10.18632/oncotarget.11117. eCollection 2017 Aug 15.

20.

Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases.

Perrino CM, Grignon DJ, Williamson SR, Idrees MT, Eble JN, Cheng L.

Histopathology. 2018 Jan;72(2):305-319. doi: 10.1111/his.13362. Epub 2017 Oct 24.

PMID:
28833389
21.

Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.

Sanfrancesco JM, Eble JN, Grignon DJ, Wang M, Zhang S, Sundaram CP, Idrees MT, Pili R, Kouba E, Cheng L.

Mol Carcinog. 2017 Nov;56(11):2527-2537. doi: 10.1002/mc.22699. Epub 2017 Aug 3.

PMID:
28667776
22.

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens.

Harari SE, Sassoon DJ, Priemer DS, Jacob JM, Eble JN, Caliò A, Grignon DJ, Idrees M, Albany C, Masterson TA, Hanna NH, Foster RS, Ulbright TM, Einhorn LH, Cheng L.

Urol Oncol. 2017 Oct;35(10):605.e9-605.e16. doi: 10.1016/j.urolonc.2017.05.018. Epub 2017 Jun 21. Review.

PMID:
28647396
23.

Variant morphology in upper urinary tract urothelial carcinoma: a 14-year case series of biopsy and resection specimens.

Hayashi H, Mann S, Kao CS, Grignon D, Idrees MT.

Hum Pathol. 2017 Jul;65:209-216. doi: 10.1016/j.humpath.2017.05.001. Epub 2017 May 12.

24.

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.

Lawton CAF, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M 3rd, Kwok Y, Dignam JJ, Sandler HM.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):296-303. doi: 10.1016/j.ijrobp.2017.02.004. Epub 2017 Feb 12.

25.

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.

Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H, Gupta NS.

Hum Pathol. 2017 May;63:149-156. doi: 10.1016/j.humpath.2017.03.004. Epub 2017 Mar 14.

26.

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM; NRG Oncology RTOG.

N Engl J Med. 2017 Feb 2;376(5):417-428. doi: 10.1056/NEJMoa1607529.

27.

Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.

Delahunt B, Grignon DJ, Samaratunga H, Srigley JR, Leite KR, Kristiansen G, Evans AJ, Kench JG, Egevad L.

Arch Pathol Lab Med. 2017 Feb;141(2):182-183. doi: 10.5858/arpa.2016-0300-LE. No abstract available.

PMID:
28134585
28.

Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.

Mirhadi AJ, Zhang Q, Hanks GE, Lepor H, Grignon DJ, Peters CA, Rosenthal SA, Zeitzer K, Radwan JS, Lawton C, Parliament MB, Reznik RS, Sandler HM.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):511-515. doi: 10.1016/j.ijrobp.2016.11.002. Epub 2016 Nov 8.

29.

Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy.

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck SDW, Grignon DJ, Cheng L, Albany C, Hahn NM.

Clin Genitourin Cancer. 2017 Aug;15(4):479-486. doi: 10.1016/j.clgc.2016.11.009. Epub 2016 Nov 30.

30.

Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?

Williamson SR, Grignon DJ, Cheng L, Favazza L, Gondim DD, Carskadon S, Gupta NS, Chitale DA, Kalyana-Sundaram S, Palanisamy N.

Am J Surg Pathol. 2017 Mar;41(3):287-298. doi: 10.1097/PAS.0000000000000776.

PMID:
28009604
31.

Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.

Calió A, Grignon DJ, Stohr BA, Williamson SR, Eble JN, Cheng L.

Mod Pathol. 2017 Mar;30(3):407-415. doi: 10.1038/modpathol.2016.200. Epub 2016 Dec 2.

32.

Cystic Nephroma in Adults: A Clinicopathologic Study of 46 Cases.

Caliò A, Eble JN, Grignon DJ, Delahunt B.

Am J Surg Pathol. 2016 Dec;40(12):1591-1600.

PMID:
27831959
33.

Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene.

Kouba E, Simper NB, Chen S, Williamson SR, Grignon DJ, Eble JN, MacLennan GT, Montironi R, Lopez-Beltran A, Osunkoya AO, Zhang S, Wang M, Wang L, Tran T, Emerson RE, Baldrige LA, Monn MF, Linos K, Cheng L.

J Clin Pathol. 2017 Jun;70(6):508-514. doi: 10.1136/jclinpath-2016-204088. Epub 2016 Oct 31.

34.

High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment.

Kouba EJ, Eble JN, Simper N, Grignon DJ, Wang M, Zhang S, Wang L, Martignoni G, Williamson SR, Brunelli M, Luchini C, Calió A, Cheng L.

Mod Pathol. 2016 Nov;29(11):1347-1357. doi: 10.1038/modpathol.2016.133. Epub 2016 Jul 29.

35.

Mixed Epithelial and Stromal Tumor of the Kidney: A Clinicopathologic Study of 53 Cases.

Caliò A, Eble JN, Grignon DJ, Delahunt B.

Am J Surg Pathol. 2016 Nov;40(11):1538-1549.

PMID:
27635943
36.

Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.

Bonsib SM, Boils C, Gokden N, Grignon D, Gu X, Higgins JP, Leroy X, McKenney JK, Nasr SH, Phillips C, Sangoi AR, Wilson J, Zhang PL.

Pathol Res Pract. 2016 Nov;212(11):972-979. doi: 10.1016/j.prp.2016.04.005. Epub 2016 Apr 30.

37.

Evidence of a dual histogenetic pathway of sacrococcygeal teratomas.

Emerson RE, Kao CS, Eble JN, Grignon DJ, Wang M, Zhang S, Wang X, Fan R, Masterson TA, Roth LM, Cheng L.

Histopathology. 2017 Jan;70(2):290-300. doi: 10.1111/his.13062. Epub 2016 Oct 10.

38.

Prostate cancer grading: recent developments and future directions.

Delahunt B, Egevad L, Grignon DJ, Srigley JR, Samaratunga H.

BJU Int. 2016 Apr;117 Suppl 4:7-8. doi: 10.1111/bju.13467. No abstract available.

39.

International Society of Urological Pathology (ISUP) Grading of Prostate Cancer.

Egevad L, Delahunt B, Evans AJ, Grignon DJ, Kench JG, Kristiansen G, Leite KR, Samaratunga H, Srigley JR.

Am J Surg Pathol. 2016 Jun;40(6):858-61. doi: 10.1097/PAS.0000000000000642. No abstract available.

PMID:
27023325
40.

Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.

Williamson SR, Gupta NS, Eble JN, Rogers CG, Michalowski S, Zhang S, Wang M, Grignon DJ, Cheng L.

Am J Surg Pathol. 2015 Nov;39(11):1502-10. doi: 10.1097/PAS.0000000000000514.

PMID:
26457355
41.

Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma.

Tran T, Jones CL, Williamson SR, Eble JN, Grignon DJ, Zhang S, Wang M, Baldridge LA, Wang L, Montironi R, Scarpelli M, Tan PH, Simper NB, Comperat E, Cheng L.

Histopathology. 2016 May;68(6):850-7. doi: 10.1111/his.12840. Epub 2015 Oct 21.

PMID:
26310887
42.
43.

Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma.

Kinney SN, Eble JN, Hes O, Williamson SR, Grignon DJ, Wang M, Zhang S, Baldrige LA, Martignoni G, Brunelli M, Wang L, Comperat E, Fan R, Montironi R, MacLennan GT, Cheng L.

Mod Pathol. 2015 Sep;28(9):1236-48. doi: 10.1038/modpathol.2015.81. Epub 2015 Aug 7.

44.

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):294-302. doi: 10.1016/j.ijrobp.2015.05.024. Epub 2015 Jul 21.

45.

Correcting the Shrinkage Effects of Formalin Fixation and Tissue Processing for Renal Tumors: toward Standardization of Pathological Reporting of Tumor Size.

Tran T, Sundaram CP, Bahler CD, Eble JN, Grignon DJ, Monn MF, Simper NB, Cheng L.

J Cancer. 2015 Jul 2;6(8):759-66. doi: 10.7150/jca.12094. eCollection 2015.

46.

Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.

Jacob JM, Williamson SR, Gondim DD, Leese JA, Terry C, Grignon DJ, Boris RS.

Urology. 2015 Nov;86(5):956-61. doi: 10.1016/j.urology.2015.06.015. Epub 2015 Jun 28.

PMID:
26126697
47.

Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR.

Simper NB, Jones CL, MacLennan GT, Montironi R, Williamson SR, Osunkoya AO, Wang M, Zhang S, Grignon DJ, Eble JN, Tran T, Wang L, Baldrige LA, Cheng L.

Hum Pathol. 2015 Jun;46(6):805-12. doi: 10.1016/j.humpath.2015.02.004. Epub 2015 Feb 26.

PMID:
25870120
48.

The application of the Johns Hopkins Hospital Template on urine cytology.

Wu HH, Redelman M, Chen S, Grignon DJ, Cramer HM.

Diagn Cytopathol. 2015 Aug;43(8):593-7. doi: 10.1002/dc.23257. Epub 2015 Feb 26.

49.

[Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations].

Rioux-Leclercq N, Ferran A, Mahul A, Argani P, Billis A, Bonsib S, Cheng L, Cheville J, Eble J, Egevad L, Epstein J, Grignon D, Hes O, Humphrey P, Magi-Galluzzi C, Martignoni G, McKenney J, Merino M, Moch H, Montironi R, Netto G, Reuter V, Samaratunga H, Shen S, Srigley J, Tamboli P, Tan PH, Tickoo S, Trpkov K, Zhou M, Delahunt B, Comperat E; International Society of Urologic Pathology.

Ann Pathol. 2014 Dec;34(6):448-61. doi: 10.1016/j.annpat.2014.10.003. Epub 2014 Nov 18. French.

PMID:
25499860
50.

Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Amin MB, Smith SC, Reuter VE, Epstein JI, Grignon DJ, Hansel DE, Lin O, McKenney JK, Montironi R, Paner GP, Al-Ahmadie HA, Algaba F, Ali S, Alvarado-Cabrero I, Bubendorf L, Cheng L, Cheville JC, Kristiansen G, Cote RJ, Delahunt B, Eble JN, Genega EM, Gulmann C, Hartmann A, Langner C, Lopez-Beltran A, Magi-Galluzzi C, Merce J, Netto GJ, Oliva E, Rao P, Ro JY, Srigley JR, Tickoo SK, Tsuzuki T, Umar SA, Van der Kwast T, Young RH, Soloway MS.

Mod Pathol. 2015 May;28(5):612-30. doi: 10.1038/modpathol.2014.158. Epub 2014 Nov 21. Review.

Supplemental Content

Loading ...
Support Center